Listeria as a vaccine vector

被引:64
作者
Bruhn, Kevin W.
Craft, Noah
Miller, Jeff F.
机构
[1] Univ Calif Los Angeles, Med Ctr, Los Angeles Biomed Res Inst, Dept Med,Div Dermatol, Torrance, CA 90502 USA
[2] Univ Calif Los Angeles, Inst Mol Biol, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA
关键词
listeria monocytogenes; vaccine vector; cancer immunotherapy;
D O I
10.1016/j.micinf.2007.05.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The immunostimulatory characteristics and intracellular niche of Listeria monocytogenes make it uniquely suitable for use as a live bacterial vaccine vector. Preclinical results supporting this idea, and current strategies to induce beneficial cell-mediated immunity to both infectious diseases and cancer with this vector, are discussed in this review. (C) 2007 Elsevier Masson SAS. All fights reserved.
引用
收藏
页码:1226 / 1235
页数:10
相关论文
共 56 条
  • [1] Safety and shedding of an attenuated strain of Listeria monocytogenes with a deletion of actA/plcB in adult volunteers:: a dose escalation study of oral inoculation
    Angelakopoulos, H
    Loock, K
    Sisul, DM
    Jensen, ER
    Miller, JF
    Hohmann, EL
    [J]. INFECTION AND IMMUNITY, 2002, 70 (07) : 3592 - 3601
  • [2] Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination
    Badovinac, VP
    Messingham, KAN
    Jabbari, A
    Haring, JS
    Harty, JT
    [J]. NATURE MEDICINE, 2005, 11 (07) : 748 - 756
  • [3] Cytosolic entry controls CD8+-T-cell potency during bacterial infection
    Bahjat, Keith S.
    Liu, Weiqun
    Lemmens, Edward E.
    Schoenberger, Stephen P.
    Portnoy, Daniel A.
    Dubensky, Thomas W., Jr.
    Brockstedt, Dirk G.
    [J]. INFECTION AND IMMUNITY, 2006, 74 (11) : 6387 - 6397
  • [4] Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity
    Brockstedt, DG
    Bahjat, KS
    Giedlin, MA
    Liu, W
    Leong, M
    Luckett, W
    Gao, Y
    Schnupf, P
    Kapadia, D
    Castro, G
    Lim, JYH
    Sampson-Johannes, A
    Herskovits, AA
    Stassinopoulos, A
    Bouwer, HGA
    Hearst, JE
    Portnoy, DA
    Cook, DN
    Dubensky, TW
    [J]. NATURE MEDICINE, 2005, 11 (08) : 853 - 860
  • [5] Listeria-based cancer vaccines that segregate immunogenicity from toxicity
    Brockstedt, DG
    Giedlin, MA
    Leong, ML
    Bahjat, KS
    Gao, Y
    Luckett, W
    Liu, WQ
    Cook, DN
    Portnoy, DA
    Dubensky, TW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (38) : 13832 - 13837
  • [6] Characterization of anti-self CD8 T-cell responses stimulated by recombinant Listeria monocytogenes expressing the melanoma antigen TRP-2
    Bruhn, KW
    Craft, N
    Nguyen, BD
    Yip, J
    Miller, JF
    [J]. VACCINE, 2005, 23 (33) : 4263 - 4272
  • [7] Cytoplasmic entry of Listeria monocytogenes enhances dendritic cell maturation and T cell differentiation and function
    Brzoza, KL
    Rockel, AB
    Hiltbold, EM
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (04) : 2641 - 2651
  • [8] Butterfield LH, 2003, CLIN CANCER RES, V9, P998
  • [9] The TLR7 agonist imiquimod enhances the anti-melanoma effects of a recombinant Listeria monocytogenes vaccine
    Craft, N
    Bruhn, KW
    Nguyen, BD
    Prins, R
    Lin, JW
    Liau, LM
    Miller, JF
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (03) : 1983 - 1990
  • [10] HER-2/neu protein: A target for antigen-specific immunotherapy of human cancer
    Disis, ML
    Cheever, MA
    [J]. ADVANCES IN CANCER RESEARCH, VOL 71, 1997, 71 : 343 - 371